Effect of bovine respiratory disease on the respiratory microbiome: a meta-analysis
Frontiers in Cellular and Infection Microbiology · 2023
DOI: 10.3389/fcimb.2023.1223090 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Samantha Howe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Science, Division of Agriculture, University of Arkansas, Fayetteville, AR, United States. Hauptthemen laut MEDLINE: Respiratory Tract Diseases, Cattle Diseases, Microbiota, Mycoplasma hyorhinis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Bovine respiratory disease (BRD) is the most devastating disease affecting beef and dairy cattle producers in North America. An emerging area of interest is the respiratory microbiome’s relationship with BRD. However, results regarding the effect of BRD on respiratory microbiome diversity are conflicting.
Results
To examine the effect of BRD on the alpha diversity of the respiratory microbiome, a meta-analysis analyzing the relationship between the standardized mean difference (SMD) of three alpha diversity metrics (Shannon’s Diversity Index (Shannon), Chao1, and Observed features (OTUs, ASVs, species, and reads) and BRD was conducted. Our multi-level model found no difference in Chao1 and Observed features SMDs between calves with BRD and controls. The Shannon SMD was significantly greater in controls compared to that in calves with BRD. Furthermore, we re-analyzed 16S amplicon sequencing data from four previously published datasets to investigate BRD’s effect on individual taxa abundances. Additionally, based on Bray Curtis and Jaccard distances, health status, sampling location, and dataset were all significant sources of variation. Using a consensus approach based on RandomForest, DESeq2, and ANCOM-BC2, we identified three differentially abundant amplicon sequence variants (ASVs) within the nasal cavity, ASV5_ Mycoplasma , ASV19_ Corynebacterium , and ASV37_ Ruminococcaceae. However, no ASVs were differentially abundant in the other sampling locations. Moreover, based on SECOM analysis, ASV37_ Ruminococcaceae had a negative relationship with ASV1_ Mycoplasma_hyorhinis , ASV5_ Mycoplasma , and ASV4_ Mannheimia . ASV19_ Corynebacterium had negative relationships with ASV1_ Mycoplasma_hyorhinis , ASV4_ Mannheimia , ASV54_ Mycoplasma , ASV7_ Mycoplasma , and ASV8_ Pasteurella .
Conclusions
Our results confirm a relationship between bovine respiratory disease and respiratory microbiome diversity and composition, which provide additional insight into microbial community dynamics during BRD development. Furthermore, as sampling location and sample processing (dataset) can also affect results, consideration should be taken when comparing results across studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Animal Science, Division of Agriculture, University of Arkansas, Fayetteville, AR, United States.
- Medical Laboratory Sciences Program, College of Health and Human Sciences, Northern Illinois University, DeKalb, IL, United States.
Zitieren
APA
Howe, S., Kegley, B., Powell, J., Chen, S., & Zhao, J. (2023). Effect of bovine respiratory disease on the respiratory microbiome: a meta-analysis. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1223090
Vancouver
Howe S, Kegley B, Powell J, Chen S, Zhao J. Effect of bovine respiratory disease on the respiratory microbiome: a meta-analysis. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1223090
BibTeX
@article{Howe2023,
author = {Howe, Samantha and Kegley, Beth and Powell, Jeremy and Chen, Shicheng and Zhao, Jiangchao},
title = {Effect of bovine respiratory disease on the respiratory microbiome: a meta-analysis},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
doi = {10.3389/fcimb.2023.1223090}
}
EUVIMED